Balda AG: Balda AG and Mechatronic AG present joint development: App-controlled drug dispenser


(DGAP-Media / 12.10.2015 / 11:14)

The Smart Drug Dispenser keeps track of tablets

Madrid, October 12, 2015 – Patients will soon be able to dose their drugs

via their smartphones. The medical technology companies Balda AG and

Mechatronic AG present the Smart Drug Dispenser exclusively within the

scope of the CPhI Worldwide in Madrid. The combination of app and

easy-to-handle drug dispenser helps prevent administration errors and thus

unnecessary complaints or hospital stays.

A signal helping patients: The Smart Drug Dispenser makes an important

contribution to the safety of the therapy. The physician or the patient may

conveniently enter the number and the time when the medication is to be

taken via the app. The device, which is about palm-sized, stores the dosage

regimen and dispenses the tablets via the push of a button. The associated

smartphone app reminds the user via text alerts and an acoustic signal that

the tablet may now be released from the device, until it has been

distributed. This prevents under or over dosage. The scientific figures

show that this support is dearly needed.

Forgotten, mistaken, lost – over 50 per cent of medication is not taken as

prescribed. According to studies, one in four patients does not follow the

therapy regimen. Not necessarily on purpose. Surveys show that many people

simply forget to take their drugs. Consequences such as extended healing

processes, secondary diseases and additional trips to the doctor are not

only bothersome for the patients. The costs to the German healthcare

systems due to deficient compliance are conservatively estimated to be in

excess of 10 billion EUR per year.

Christoph Klaus, Head of the Business Unit Balda Healthcare has recognized

the potential of the system: “An ageing population that is also tech-savvy

has a need for modern solutions. The Smart Drug Dispenser is an exciting

product that provides added value both for patients, physicians, relatives

and also health insurers”. Also Thomas Ullmann from Mechatronic AG is

pleased with the result of the cooperation of the development service

provider and the plastics specialist: “With the Smart Drug Dispenser, we

have taken an innovative step in the direction of user-friendly operation

whilst offering a high degree of user safety”.

Balda AG and Mechatronic AG will present their joint project between 13 and

15 October within the scope of the CPhI Worldwide in Madrid. Visitors may

test the Smart Drug Dispenser at booth 4B80 in hall 4.

Balda AG (ISIN: DE0005215107) is a provider of high-end plastics solutions

that rely on quality in sophisticated fields of application in the

healthcare, lifestyle, automotive and consumer electronics industry.

Balda operates in Europe and Northern America and has state of the art

production sites at the Oeynhausen headquarters in Germany and in the US.

The company’s success with its about 800 staff worldwide is based on the

use of modern, cost-efficient technologies and the close cooperation with

our customers in a spirit of trust.

Mechatronic AG is an international specialist in the development and

production of medical devices and the provision of services, software

products and test systems in the field of medical technology. Since 1987,

the company has been carrying out development and manufacturing work on

behalf of its customers, who can rely on its long-standing experience in

the industry and extensive expertise regarding processes and methods. Its

portfolio ranges from new developments and the redesign of existing

products and components to individual service modules.


Balda AG

Kathrin Wiederrich

Bergkirchener Str. 229

32549 Bad Oeynhausen

Tel: +49 5734 922 2023

Mobil: +49 176 19227157


Mechatronic AG

Ricarda Groß

Wittichstr. 2

64295 Darmstadt

+49 6151 5003 172




DiMatteo, M. R., Variations in patients adherence to medical

recommendations: a quantitative review of 50 years of research. Med. Care

42 (2004) 200-209.



Michaela Gräf: Die volkswirtschaftlichen Kosten der Non-Compliance: Eine

entscheidungsorientierte Analyse. P.C.O.-Verlag; edition: 1st, ed. (August

13, 2007)


End of Media Release


Issuer: Balda AG

Key word(s): Industry

12.10.2015 Dissemination of a Press Release, transmitted by DGAP – a

service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at and


Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen


Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604



ISIN: DE0005215107

WKN: 521510

Listed: Regulated Market in Frankfurt (Prime Standard); Regulated

Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,

Munich, Stuttgart

End of News DGAP Media


401787 12.10.2015